» Articles » PMID: 22906327

Routine Anticoagulation for Venous Thromboembolism Prevention Following Laparoscopic Gastric Bypass

Overview
Journal JSLS
Specialty General Surgery
Date 2012 Aug 22
PMID 22906327
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare the rates of venous thromboembolism (VTE) by using routine postoperative enoxaparin versus early ambulation, SCDs, hydration, and selective prophylactic pharmacologic anticoagulation.

Methods: 1,692 patients undergoing laparoscopic gastric bypass from October 2001 to October 2008 were included and divided into 2 groups based on when they were operated upon. Group A (435 patients) received routine enoxaparin 12 hours after surgery. Group B (1,257 patients) received selective pharmacologic anticoagulation, in high-risk patients only.

Results: Mean operating time was 144±26 minutes (Group A) and 126±15 minutes (Group B). Mean length of stay was 2.3±1.5 days for Group A and 1.4±1.2 for Group B. Intraluminal bleeding occurred in 21 patients (4.8%) in Group A and 5 (0.9%) in Group B; none required intervention. Five pulmonary embolisms occurred in Group A (1.1%) and none in Group B. Seven patients in Group A (1.7%) and 6 (0.47%) in Group B had clinically evident DVT. Two non-VTE related deaths occurred in Group A.

Conclusions: Adequate VTE prophylaxis is achieved using SCDs, early ambulation, emphasis on hydration, and shorter operating times. Bariatric surgery can be safely performed without pharmacologic VTE prophylaxis in all but the high-risk population. Fewer bleeding complications occur without the use of anticoagulants.

Citing Articles

Single-Dose enoxaparin for portomesenteric venous thrombosis prophylaxis after sleeve gastrectomy.

Nofal M, Wadi W, Yousef A, Rashdan M, Alkhasawneh M, Dwairi R Ann Afr Med. 2024; 23(1):46-52.

PMID: 38358171 PMC: 10922185. DOI: 10.4103/aam.aam_133_23.


Thromboembolic Complications After Bariatric Surgery: Is the High Risk Real?.

Carvalho L, Almeida R, Nora M, Guimaraes M Cureus. 2023; 15(1):e33444.

PMID: 36628392 PMC: 9817412. DOI: 10.7759/cureus.33444.


Mechanical prophylaxis for venous thromboembolism prevention in obese individuals.

Khatri A, Davies A, Shalhoub J Phlebology. 2021; 36(10):768-770.

PMID: 34229501 PMC: 8652370. DOI: 10.1177/02683555211031147.


Effectiveness of ambulation to prevent venous thromboembolism in patients admitted to hospital: a systematic review.

Lau B, Murphy P, Nastasi A, Seal S, Kraus P, Hobson D CMAJ Open. 2020; 8(4):E832-E843.

PMID: 33293333 PMC: 7743906. DOI: 10.9778/cmajo.20200003.


Thromboprophylaxis after bariatric surgery.

Almarshad F, Almegren M, Alshuaibi T, Alobaodi N, Almutawa A, Basunbl H Blood Res. 2020; 55(1):44-48.

PMID: 32269974 PMC: 7106117. DOI: 10.5045/br.2020.55.1.44.


References
1.
. ASMBS updated position statement on prophylactic measures to reduce the risk of venous thromboembolism in bariatric surgery patients. Surg Obes Relat Dis. 2013; 9(4):493-7. DOI: 10.1016/j.soard.2013.03.006. View

2.
Bajardi G, Ricevuto G, Mastrandrea G, Latteri M, Pischedda G, Rubino G . [Postoperative venous thromboembolism in bariatric surgery]. Minerva Chir. 1993; 48(10):539-42. View

3.
Geerts W, Pineo G, Heit J, Bergqvist D, Lassen M, Colwell C . Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126(3 Suppl):338S-400S. DOI: 10.1378/chest.126.3_suppl.338S. View

4.
Simone E, Madan A, Tichansky D, Kuhl D, Lee M . Comparison of two low-molecular-weight heparin dosing regimens for patients undergoing laparoscopic bariatric surgery. Surg Endosc. 2008; 22(11):2392-5. DOI: 10.1007/s00464-008-9997-6. View

5.
Meyering C, Howard T . Hypercoagulability in athletes. Curr Sports Med Rep. 2004; 3(2):77-83. DOI: 10.1249/00149619-200404000-00005. View